Stay current on changes and developments in corporate law with a wide variety of resources and tools.
By Jacob Rund
A former director of a UnitedHealth Group Inc. subsidiary is suing the parent company for millions in shares he claims were withheld from him when the companies merged last year.
A lawsuit filed April 17 in Delaware Chancery Court alleges CentrifyHealth Inc. breached multiple contracts by failing to provide Richard Forman, a former board member and investor, with promised stock options and a 1 percent equity stake.
UnitedHealth acquired CentrifyHealth, a Nashville, Tenn.-based technology company, in August 2017 for about $113 per share worth of UnitedHealth stock, plus $180 in stock per share for milestone payments.
According to the complaint, CentrifyHealth’s founder told Forman he was entitled to 1 percent of the company in “founders shares” for “active participation as a board member and/or investor.” The promise was made over email and wasn’t formalized in a contract.
The lawsuit also alleges that, while on the board, Forman was authorized to receive 8,000 stock options, but he never received a copy of the option plan.
Forman resigned from the board in 2010. When he contacted the company in 2017, he was told he only held preferred shares he had purchased himself, the complaint said.
Forman “has been deprived of several million dollars, possibly close to $9 million in value in connection with the merger,” the complaint said.
The lawsuit accuses five former CentrifyHealth directors of breaching their fiduciaries duties by failing to provide details of the stock option awards and disclosing that the options would be forfeited if Forman left the board.
Forman is asking the court to force UnitedHealth to either issue him the shares he claims to have been entitled to in the merger, or for damages equal to “the highest interim value that UnitedHealth stock reaches” until the lawsuit is resolved.
A UnitedHealth spokesperson did not immediately respond to a request for comment.
The case is Forman v. CentrifyHealth Inc. , Del. Ch., No. 2018-0287, complaint filed 4/17/18 .
To contact the reporter on this story: Jacob Rund in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Fawn Johnson at email@example.com
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)